デフォルト表紙
市場調査レポート
商品コード
1466548

臓器移植市場:タイプ別、エンドユーザー別 - 2024年~2030年の世界予測

Organ Transplantation Market by Type (Heart Transplantation, Kidney Transplantation, Liver Transplantation), End User (Hospitals & Care Providers, Transplant Centers) - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.96円
臓器移植市場:タイプ別、エンドユーザー別 - 2024年~2030年の世界予測
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臓器移植市場規模は2023年に164億5,000万米ドルと推計され、2024年には180億7,000万米ドルに達し、CAGR 10.30%で2030年には326億9,000万米ドルに達すると予測されます。

臓器移植市場には、臓器置換療法を必要とする患者への人体臓器の調達、流通、移植に関連するすべての活動が含まれます。臓器提供機関、移植センター、ヘルスケア施設、抗拒絶反応薬を提供する製薬会社、人工臓器や支援技術を開発するバイオメディカル企業などの利害関係者が含まれます。最終用途には、欠陥のある臓器をドナーからの機能する臓器に置き換える臨床処置、医療フォローアップ、移植前後の継続的な患者ケアが含まれます。臓器移植市場の成長には、臓器移植手術件数の増加、慢性疾患の有病率の増加と臓器不全事例の加速、臓器提供者と移植の合法化ルートの開拓など、いくつかの要因が寄与しています。しかし、臓器提供者の不足や治療費の高騰、臓器拒絶反応や移植後の合併症のリスク、臓器移植における社会的・倫理的懸念など、いくつかの限界や課題が臓器移植の採用に影響を与えています。一方、臓器移植法の技術的進歩、臓器提供に対する意識の高まり、臓器や組織の3Dバイオプリンティングの進歩、拒絶反応や合併症のリスクを軽減するための個別化免疫抑制プロトコルは、今後数年間の臓器移植市場に潜在的なビジネスチャンスをもたらします。

主な市場の統計
基準年[2023年] 164億5,000万米ドル
予測年[2024年] 180億7,000万米ドル
予測年 [2030年] 326億9,000万米ドル
CAGR(%) 10.30%

タイプ腎臓病の増加による腎臓移植の急増

心臓移植は、末期心不全や極度の冠動脈疾患の患者が他の外科的治療に失敗した場合に行われる重要な外科手術です。ドナーとなる心臓が限られているため、通常、心臓移植の需要が供給を上回っています。腎臓移植は、病気の腎臓をドナーの健康な腎臓に置き換えるものです。この種の移植は、高血圧や糖尿病に起因する腎臓病の罹患率の増加により、高い需要があります。腎臓移植は通常、他の臓器移植よりも一般的であるが、それは腎臓が生体ドナーから提供され、ドナープールを増やすことができるからです。肝移植は、ドナーの肝臓の全部または一部を移植する手術です。この手術は主に、肝硬変やC型肝炎などの疾患による末期肝疾患や急性肝不全の患者に適応されます。肝移植の市場には、免疫抑制のための医薬品や、臓器保存ソリューションに携わるバイオテクノロジー企業が含まれます。肺移植は、病気の肺をドナーの健康な肺と置き換えるものです。一般的には、慢性閉塞性肺疾患(COPD)、嚢胞性線維症、肺線維症など、生命を脅かす重度の肺疾患を患っている人に行われます。膵臓移植は通常、1型糖尿病の治療のために行われ、腎臓移植と併用されることが多いです。この手術により、糖尿病患者のインスリン療法を不要にすることができます。

エンドユーザー:スタッフの専門性と技術により、移植センターにおける臓器移植は進化しています。

臓器移植のプロセスにおいて、病院とケアプロバイダーは極めて重要な役割を果たしています。彼らは潜在的なレシピエントの最初の接点であり、治療の診断と移植後のケアを促進します。臓器の生存性を確保するための高品質で信頼性の高い臓器保存・搬送システム、高度な手術機器、複雑な移植手術に対応した手術室技術などが、彼らのニーズに基づいた嗜好品です。移植センターは、臓器移植に特化した専門施設です。スタッフや技術の専門性という点で、より高度な施設となる傾向があります。移植センターでは、最新の免疫抑制剤プロトコールや治療法、ドナーとレシピエントのマッチングをより確実にするための高度な組織タイピング技術などが、ニーズに応じて選択されます。

地域別インサイト

南北アメリカは、強固なヘルスケア・インフラ、確立された臓器提供ネットワーク、研究開発への多額の投資により、臓器移植において急速な成長を示しています。米国の消費者は臓器提供や臓器移植に関して高い意識を持っており、関連サービスへの大きな需要につながっています。南米の臓器移植市場は、ブラジルやアルゼンチンなどを筆頭に拡大しています。臓器提供率を高め、移植サービスを改善するための政府の取り組みが市場を牽引しています。欧州は、強固なヘルスケア・インフラと包括的な臓器移植政策を示しており、スペインをはじめとする国々は、その効率的なドナー管理システムが評価されています。先進技術の導入と専門的な移植サービスの利用可能性が、この市場の成長に寄与しています。中東は、ヘルスケア支出の増加と規制の枠組みの発展により、臓器移植市場の成長を示しています。文化的・宗教的要因は、臓器提供や移植に関する消費者行動に大きな影響を与えます。アフリカでは、インフラの課題やヘルスケアの格差が臓器移植の妨げとなっています。しかし、一部の地域では移植プログラムの確立に向けて前進しているが、資金、国民の意識、規制上のハードルなどの障害に直面しています。APAC地域は、慢性疾患の増加、ヘルスケア支出の増加、臓器提供を促進する政府の取り組みによって、臓器移植市場が急速に開拓されています。中国は、ヘルスケア・インフラへの多額の投資と中間層の増加により、臓器移植で急速に成長しています。日本は医療制度が確立されているが、高齢化と臓器提供に対する文化的抵抗感という課題があります。インドは、医療サービスへのアクセスに大きな格差がある複雑な臓器移植市場です。特に都市部では需要が高まっており、民間病院が移植サービスを主導しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは臓器移植市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、臓器移植市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1.臓器移植市場の市場規模および予測は?

2.臓器移植市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3.臓器移植市場の技術動向と規制枠組みは?

4.臓器移植市場における主要ベンダーの市場シェアは?

5.臓器移植市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 臓器移植手術件数の増加
      • 慢性疾患の増加と臓器不全の増加
      • 臓器提供と移植のための合法的なチャネルの開発
    • 抑制要因
      • 臓器提供者の不足と治療費の高騰
    • 機会
      • 臓器移植手法における技術的進歩
      • 臓器提供への意識向上
    • 課題
      • 臓器移植における社会的および倫理的懸念
  • 市場セグメンテーション分析
    • タイプ:腎臓疾患の増加により腎臓移植が急増
    • エンドユーザー:スタッフと技術の専門化により移植センターの臓器移植が進化
  • 市場動向分析
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制枠組みの分析
  • 顧客のカスタマイズ

第6章 臓器移植市場:タイプ別

  • 心臓移植
  • 腎臓移植
  • 肝臓移植
  • 肺移植
  • 膵臓移植

第7章 臓器移植市場:エンドユーザー別

  • 病院と介護サービス提供者
  • 移植センター

第8章 南北アメリカの臓器移植市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋の臓器移植市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの臓器移植市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • 市場シェア分析、2023年
  • FPNVポジショニングマトリックス、2023年
  • 競合シナリオ分析
    • TransMedicsがSummit Aviationを買収する正式契約を締結し、TransMedicsの航空能力を臓器移植向けに拡大
    • LiveOnNYとMediGOが協力し、臓器提供と移植エコシステム内の透明性と説明責任を高めるリアルタイム臓器追跡技術を発表
    • PAHOとスペイン、南北アメリカにおける臓器提供と移植の強化に関する協定に署名

第12章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. ORGAN TRANSPLANTATION MARKET RESEARCH PROCESS
  • FIGURE 2. ORGAN TRANSPLANTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ORGAN TRANSPLANTATION MARKET DYNAMICS
  • FIGURE 7. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ORGAN TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. ORGAN TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ORGAN TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HEART TRANSPLANTATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HEART TRANSPLANTATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY KIDNEY TRANSPLANTATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY KIDNEY TRANSPLANTATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PANCREAS TRANSPLANTATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PANCREAS TRANSPLANTATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 32. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 34. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 35. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 36. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 37. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 38. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 39. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 40. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 41. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 42. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 43. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 46. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 50. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 52. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 62. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 63. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 66. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 67. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 70. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 71. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 74. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 75. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 78. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 82. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 86. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 90. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 94. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 95. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 102. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 103. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 106. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 113. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 116. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 117. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 120. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 121. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 128. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 129. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 132. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 133. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 136. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 137. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 140. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 144. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 145. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 148. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 149. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 156. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 157. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 160. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 161. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 164. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 168. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 173. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 176. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 177. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 180. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 184. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 185. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 188. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 196. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 197. ORGAN TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 198. ORGAN TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-437896AA3BAA

[181 Pages Report] The Organ Transplantation Market size was estimated at USD 16.45 billion in 2023 and expected to reach USD 18.07 billion in 2024, at a CAGR 10.30% to reach USD 32.69 billion by 2030.

The organ transplantation market encompasses all activities related to procuring, distributing, and transplanting human organs to patients requiring organ replacement therapy. It includes stakeholders such as organ donation agencies, transplant centers, healthcare facilities, pharmaceutical companies that provide anti-rejection medications, and biomedical companies that create artificial organs and support technologies. Application and end-use involve clinical procedures for replacing a faulty organ with a functioning organ from a donor, medical follow-up, and ongoing patient care for pre-and post-transplant scenarios. Several factors contribute to the growth of the organ transplantation market, including an increasing number of organ transplantation surgeries, the increasing prevalence of chronic diseases and accelerating cases of organ failure, and the development of legalized channels for organ donors and transplants. However, several limitations and challenges impact the adoption of organ transplantation, such as shortage of organ donors and high cost of treatment, risk of organ rejection and post-transplant complications, and social and ethical concerns in organ transplantation. On the other hand, technological advancement in organ transplantation methods, increasing awareness of organ donation, advancements in 3D bioprinting of organs and tissues, and personalized immunosuppression protocols to reduce the risk of rejection and complications present potential opportunities for the organ transplantation market in the coming years.

KEY MARKET STATISTICS
Base Year [2023] USD 16.45 billion
Estimated Year [2024] USD 18.07 billion
Forecast Year [2030] USD 32.69 billion
CAGR (%) 10.30%

Type: Burgeoning kidney transplantation due to the increasing incidence of kidney diseases

Heart transplantation is a critical surgical procedure performed on patients with end-stage heart failure or extreme coronary artery disease when other surgical treatments fail. The demand for heart transplants usually outweighs the supply due to the limited availability of donor hearts. Kidney transplantation involves replacing a diseased kidney with a healthy one from a donor. This type of transplant is in high demand owing to the increasing incidence of kidney diseases, often resulting from hypertension and diabetes. Kidney transplants are usually more common than other organ transplants because kidneys can be donated by living donors, increasing the donor pool. Liver transplantation is the surgical alteration of a diseased liver with a complete or partial liver from a donor. This procedure is primarily indicated for patients with end-stage liver disease or acute liver failure, often due to conditions such as cirrhosis or hepatitis C. The market for liver transplantation includes pharmaceuticals for immunosuppression, along with biotechnology companies engaged in organ preservation solutions. Lung transplantation replaces diseased lungs with healthy lungs from a donor. It is generally reserved for individuals suffering from severe, life-threatening lung conditions such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, or pulmonary fibrosis. Pancreas transplantation is usually performed to treat type 1 diabetes, often in conjunction with kidney transplantation. This procedure can eliminate the need for insulin therapy for diabetic patients.

End User: Evolving organ transplantation in transplant centers owing to the specialization of staff and the technology

Hospitals and care providers play a pivotal role in the organ transplantation process. They are potential recipients' first point of contact and facilitate diagnosing treatment and post-transplant care. Their need-based preferences include high-quality, reliable organ preservation and transport systems to ensure organ viability, advanced surgical equipment, and operating room technology tailored for complex transplant operations. Transplant centers are specialized facilities that focus exclusively on organ transplants. They tend to be more advanced in terms of the specialization of staff and technology. Transplant centers' need-based preferences include the latest immunosuppressive drug protocols, treatments, and advanced tissue-typing technology to ensure better donor-recipient matches.

Regional Insights

The Americas represents a rapid growth in organ transplantation due to a robust healthcare infrastructure, established organ donation networks, and significant investments in research and development. Consumers in the US show high awareness regarding organ donation and transplantation, leading to substantial demand for related services. The organ transplantation market in South America is expanding, with countries such as Brazil and Argentina at the forefront. The markets are driven by governmental initiatives to increase organ donation rates and improve transplantation services. Europe exhibits a robust healthcare infrastructure and comprehensive organ transplant policies, with countries, including Spain, recognized for their efficient donor management systems. The incorporation of advanced technologies and the availability of specialized transplantation services contribute to the growth of this market. The Middle East showcases a growing organ transplant market driven by increasing healthcare spending and evolving regulatory frameworks. Cultural and religious factors significantly impact consumer behavior concerning organ donation and transplants. In Africa, organ transplantation activities are hindered by infrastructure challenges and disparities in healthcare. However, some regions are making strides in establishing transplantation programs but face obstacles with funding, public awareness, and regulatory hurdles. The APAC region is experiencing rapid development in the organ transplantation market, driven by the increasing prevalence of chronic diseases, rising healthcare expenditures, and government initiatives to promote organ donation. China is rapidly growing in organ transplantation due to substantial investments in healthcare infrastructure and a growing middle class. Japan has a well-established healthcare system, with specific challenges related to an aging population and cultural resistance to organ donation. India represents a complex organ transplant market with vast disparities in access to healthcare services. There's growing demand, particularly within urban centers, with private hospitals leading transplantation services.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Organ Transplantation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Organ Transplantation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Organ Transplantation Market, highlighting leading vendors and their innovative profiles. These include 21st Century Medicine, AbbVie Inc., Arthrex, Inc., Artivion, Inc., Astellas Pharma Inc., Bio-Rad Laboratories, Inc., BiolifeSolutions, Inc., CHIESI Farmaceutici S.p.A. by Amryt Pharma PLC, Dr. Franz Kohler Chemie GmbH, Exactech, Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Medtronic PLC, NHS Blood and Transplant, Novartis AG, Organ Recovery Systems, Organovo Holdings, Inc., OrganOx Limited, Pfizer Inc., Plexision, Preservation Solutions, Inc., Sanofi S.A., Stryker Corporation, Teva Pharmaceuticals Industries Ltd., Thermo Fisher Scientific Inc., TransMedics Group, Inc., Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp., and Xvivo Perfusion AB.

Market Segmentation & Coverage

This research report categorizes the Organ Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Heart Transplantation
    • Kidney Transplantation
    • Liver Transplantation
    • Lung Transplantation
    • Pancreas Transplantation
  • End User
    • Hospitals & Care Providers
    • Transplant Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Organ Transplantation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Organ Transplantation Market?

3. What are the technology trends and regulatory frameworks in the Organ Transplantation Market?

4. What is the market share of the leading vendors in the Organ Transplantation Market?

5. Which modes and strategic moves are suitable for entering the Organ Transplantation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Number of Organ Transplantation Surgeries
      • 5.1.1.2. Increasing Prevalence of Chronic Diseases and Accelerating Cases of Organ Failure
      • 5.1.1.3. Development of Legalized Channel for Organ Donors and Transplants
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of Organ Donors and High Cost of Treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancement in Organ Transplantation Methods
      • 5.1.3.2. Increasing Awareness of Organ Donation
    • 5.1.4. Challenges
      • 5.1.4.1. Social and Ethical Concerns in Organ Transplantation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Burgeoning kidney transplantation due to the increasing incidence of kidney diseases
    • 5.2.2. End User: Evolving organ transplantation in transplant centers owing to the specialization of staff and the technology
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Organ Transplantation Market, by Type

  • 6.1. Introduction
  • 6.2. Heart Transplantation
  • 6.3. Kidney Transplantation
  • 6.4. Liver Transplantation
  • 6.5. Lung Transplantation
  • 6.6. Pancreas Transplantation

7. Organ Transplantation Market, by End User

  • 7.1. Introduction
  • 7.2. Hospitals & Care Providers
  • 7.3. Transplant Centers

8. Americas Organ Transplantation Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Organ Transplantation Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Organ Transplantation Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. TransMedics Signs Definitive Agreement to Acquire Summit Aviation to Expand TransMedics Aviation Capabilities for Organ Transplantation
    • 11.3.2. LiveOnNY and MediGO Collaborate to Launch Real-Time Organ Tracking Technology to Increase Transparency and Accountability Within the Organ Donation and Transplant Ecosystem
    • 11.3.3. PAHO and Spain Sign Agreement to Strengthen Organ Donation and Transplant in the Americas

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio